We initiated a transgenic model for primary pulmonary neuroendocrine cell (
PNEC) hyperplasia/neoplasia using v-Ha-ras driven by the neural/neuroendocr
ine (NE)-specific calcitonin promoter (rascal). Previously, we showed that
nitrosamine treated rodents develop PNEC hyperplasia but non-NE lung tumors
, with variable outcomes presumably reflecting ras activation in multiple c
ell lineages. Interestingly, all rascal transgenic mouse lineages develop h
yperplasias of NE and non-NE cells but mostly non-NE lung carcinomas, with
rascal mRNA in differentiated PNECs and tumor cells. Analyses of embryonic
lung demonstrate rascal mRNA in undifferentiated epithelium, consistent wit
h expression in a common pluripotent precursor cell. These unexpected obser
vations indicate that v-Ha-ras can lead to both NE and non-NE hyperplasia/n
eoplasia in vivo, opening new avenues for studies of lung carcinogenesis.